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Purpose: To determine the correlation between the changes in the central retinal sensitivity 
and the changes in the foveal thickness (FT) after photodynamic therapy (PDT) for age-related 
macular degeneration (AMD).
Methods: Nineteen eyes of 19 patients with choroidal neovasularizations (CNVs) secondary 
to AMD were studied. The pretreatment values of the central retinal sensitivity determined 
by Micro Perimeter 1 (MP1; Nidek Technologies), best-corrected visual acuity (BCVA), and 
optical coherence tomography (OCT)-determined FT were compared to the postoperative values 
at three and six months after PDT.
Results: At six months, the retinal sensitivity within the central 10° was significantly improved 
(P = 0.02) and the FT was significantly thinner (P = 0.016). The BCVA, however, did not 
change significantly (P = 0.80). The changes in the retinal sensitivities were significantly cor-
related with the changes in the decrease in the FT (r = -0.59, P = 0.012 within the central 10°) 
at six months after PDT.
Conclusion: Significant improvements in retinal sensitivities within the central 10° and a 
decrease in FT were observed even though the BCVA was not significantly improved. The 
measurement of retinal sensitivity by MP1 may be a better method to assess central visual 
function than the conventional visual acuity after PDT.
Keywords: age-related macular degeneration, fundus-related microperimetry, optical coherence 
tomography, photodynamic therapy
Introduction
Photodynamic therapy (PDT) with verteporfin has been shown to reduce the degree 
of vision decrease in patients with a subfoveal choroidal neovascularization (CNV) 
secondary to age-related macular degeneration (AMD) and polypoidal choroidal 
vasculopathy (PCV).1–4 PDT also results in a resolution of exudative and/or hemor-
rhagic lesions leading to a reduction of foveal thickness (FT) measured by optical 
coherence tomography (OCT).5,6
The distance visual acuity (VA) is the standard method of assessing the central 
visual function that is used routinely in the clinic. However, patients are often encoun-
tered who state that their central vision has improved and ophthalmoscopy showed 
a reduction of the exudation after the PDT, even though their conventional VA was 
not improved. These cases suggested that VA does not necessarily measure the visual 
quality, and may not represent the practical foveal or macular function.
It has been established that fundus-related perimetry can be used to measure macu-
lar function.7–9 Micro Perimeter 1 (MP1; Nidek Technologies, Gamagori, Japan) is a Clinical Ophthalmology 2009:3 484
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recently introduced fundus-related microperimetry, which 
is used to obtain quantitative and reliable measurements of 
retinal sensitivity which corrects for eye movements during 
the measurements. This allows for more accurate measure-
ments of the central retinal sensitivities even in patients with 
unstable fixation, and the perimetric findings from MP1 are 
comparable to those obtained by scanning laser ophthal-
moscopy (SLO).10 The software programs of the MP1 can 
superimpose the retinal sensitivities on digital fundus images. 
In eyes with PCV , the retinal sensitivity measured by MP1 
has been shown to improve shortly after PDT.11
The purpose of this study was to determine the central 
retinal sensitivities after PDT in eyes with AMD, and to 
correlate the changes in the central retinal sensitivities with 
the changes in the best-corrected VA (BCVA) and with the 
FT measured by OCT after PDT.
Materials and methods
Nineteen eyes of 19 patients that underwent PDT as an initial 
treatment for CNV secondary to AMD were studied. Of the 
19 eyes, five had predominantly classic CNV, three had 
occult CNV with no signs of classic CNV , one had minimally 
classic CNV , and 10 had PCV . Eyes that underwent a second 
PDT within six months, and eyes that had other medical 
treatments for AMD, eg, transpupillary thermotherapy 
and macular photocoagulation, were excluded. The age 
of the patients ranged from 57 to 91 years with a mean of 
71.4 ± 7.3 years ( ± SD).
The procedures used conformed to the tenets of the 
Declaration of Helsinki, and informed consent was obtained 
from all subjects after the nature and possible consequences 
of the study were explained.
Fundus-related microperimetry was performed with MP1 
using the software available for the 2006 model (Version: 
MP1 SW 1.4.2.SP1; Nidek Technologies) with automated 
corrections for eye movements. The follow-up examinations 
used a program which automatically selects the retinal sites 
that are exactly over the previously tested retinal points.
The auto-tracking system calculates the x and y positions, 
and the rotational shifts relative to a reference frame obtained 
by an infrared camera at the beginning of the examination. 
The Goldmann III stimulus with a 4–2 staircase strategy 
was used, and a rectangular 3° test grid with 24 stimulus 
locations covering an area of 10° was examined (Figure 1). 
The stimuli were projected on a white background with a 
luminance of 1.27 cd/m2 and a stimulus duration of 100 msec. 
The differential luminance, defined as the difference 
between stimulus luminance and background luminance, 
was 127 cd/m2 at 0 dB stimulation, and the maximum 
stimulus attenuation was 20 dB.
PDT with verteporphin was performed with the standard 
protocol. MP1 examinations and other comprehensive 
ophthalmic examinations including measurement of  BCVA, 
OCT, and indirect ophthalmoscopy were performed before 
treatment, and at three and six months after PDT. Fluorescein 
angiography (FA) and indocyanine green angiography 
(ICGA) were performed on all patients before and at three 
months after PDT.
From the FA/ICGA findings at three months after PDT, 
eyes were classified as those with “no leakage” from the CNV , 
“minor leakage”, and “progression” group, ie, leakage extend-
ing beyond the area of the lesion identified at the baseline.
The BCVA was measured with a standard Landolt C 
chart, and the values were converted to the logarithm of the 
minimal angle of resolution (logMAR) units. The FT was 
defined as the distance between the vitreoretinal interface 
and the retinal pigment epithelium in the center of the fovea 
using the Stratus OCT3000 (Carl Zeiss Meditec, Dublin, 
CA, USA).
Patients who stated that they had a definite improvement in 
their central visual disturbance at six months after PDT 
were grouped in the Yes group, and patients who stated that 
they had no changes or had a decrease in their central visual 
disturbance were grouped together in the Other group.
The numerical data were analyzed by the Wilcoxon 
signed-rank test. Bivariate relationships were assessed 
using the Spearman’s correlation test. A P value of   0.05 
was considered statistically significant. The changes in 
retinal sensitivity were defined as the difference in retinal 
sensitivity (dB) at baseline (pre-treatment) from the post-
treatment retinal sensitivity in dB. The changes in the FT 
were defined as the ratio of the FT at baseline divided by 
Fovea
Central 2º
Central 10º
Figure 1 Results of microperimetry.   Twenty-four loci covering the central 10° were 
examined by Micro Perimeter 1 (MP1).  Four measurement points were located within 
the central 2° of the macula, and 24 measurement points were located within the 
central 10° of the macula.Clinical Ophthalmology 2009:3 485
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the post-treatment FT. Changes in the BCVA were defined 
as the difference of the BCVA in logMAR units at baseline 
subtracted from the post treatment logMAR BCVA.
Results
The fundus photographs, OCT images, and microperimetric 
results before, and at three and six months after PDT 
obtained from a 61-year-old man are shown in Figure 2. His 
BCVA improved slightly from 20/60 to 20/50 at six months 
after PDT, and the mean retinal sensitivity within the 
central 10° improved from 5.0 dB at baseline to 9.1 dB at 
three months and to 11.8 dB at six months after PDT.
The mean changes in the best-corrected BCVA in logMAR 
units, FT, and retinal sensitivities from baseline at three and 
six months after PDT are presented in Table 1. Although the 
FT was reduced significantly after PDT at both three and six 
months (P = 0.0015 and P = 0.016, respectively), the changes 
in BCVA from baseline was not statistically significant. 
The improvement in the mean retinal sensitivities within 
the central 10° was statistically significant at six months 
(P = 0.02), but not statistically significant within the central 
2° (P = 0.39 at three months and P = 0.11 at six months).
The relationship between the changes in retinal sensitivity 
from the baseline after PDT and changes from baseline in the 
BCVA or FT after PDT are shown in the scatter diagrams 
(Figures 3–5). The changes in the BCVA was significantly 
correlated with the changes in FT at six months after PDT 
(r = 0.51; P = 0.03), and not significantly correlated with 
the changes in FT at three months after PDT (r = 0.46; 
P = 0.05) (Figure 3). The changes in retinal sensitivities 
Figure 2 Fundus photographs, fluorescein angiograms, optical coherence tomographic (OCT) images, and Micro Perimeter 1 (MP1) images from a 61-year-old man (Case 1) 
whose visual acuity (VA) was reduced to 20/60 secondary to classic and occult choroidal neovascularization (CnV) in his left eye.    Top left: Fundus photograph showing subretinal 
hemorrhage and classic CnV (white arrow) before treatment.   Top middle: Fluorescein angiogram (FA) showing minimally classic CnV. Photodynamic therapy was performed 
with a 3500 ìm laser spot on the area indicated by the yellow dotted circle.   Top right: Fundus photograph three months after photodynamic therapy (PDT) shows fibrosis of 
CnV and absorption of subretinal hemorrhage.    VA was 20/50 at three and six months after PDT.  Middle row, left: OCT image before PDT.  Middle row, middle: OCT image 
three months after PDT showing a reduction in the size of the CnV.  Middle row, right: OCT image at six months after PDT showing a reduction of foveal thickness. Bottom 
left:  MP1 image shows a dense scotoma (not seen at 0 dB) in CnV component and subretinal hemorrhage.  Mean retinal sensitivity within the central 10° is 5.0 dB before PDT. 
Bottom middle:  Mean retinal sensitivity improved to 9.1dB at three months after PDT.  Bottom right:  Mean retinal sensitivity improved to 11.8 dB at six months after PDT.    The 
patient did not report an improvement of the central visual disturbance of the left eyes. FA shows no leakage from CnV at three months after PDT.Clinical Ophthalmology 2009:3 486
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was significantly correlated with the changes in FT within 
the central 2° (r = -0.49; P = 0.038) and within the central 
10° (r = -0.59; P = 0.012) at six months after PDT (Figure 4). 
The correlations between the changes in retinal sensitivity 
and the BCVA were not significant within the central 
2° (r = -0.39; P = 0.09) and within the central 10° (r = -0.39; 
P = 0.09) at six months after PDT (Figure 5).
At six months after PDT, 14 patients (74%) reported 
that their central vision had improved, however only two of 
these patients had gained more than 0.2 logMAR units and 
the mean change in VA was -0.09 ± 0.12 in these patients 
(Table 2). A comparison of the mean change in retinal 
sensitivity at six months between patients who reported an 
improvement and those who did not report an improvement 
showed that there was a significant improvement in the retinal 
sensitivity in patients who reported a subjective improvement 
(Table 2; P = 0.016 within central 2° and P = 0.04 within 
central 10°; Mann–Whitney U test), as well as those with a 
reduction in the FT (P = 0.012; Mann–Whitney U test).
FA showed no leakage from the CNV in 10 eyes (53%), 
minor leakage in six eyes (32%), and progression of the 
CNV in three (15%) eyes at three months after PDT. Three 
patients with CNV progression refused additional treatments. 
A comparison of the mean change in retinal sensitivity and 
VA between eyes with no leakage from CNV and eyes with 
minor leakage or advancement of the CNV at three months 
after PDT is shown in Table 3. A significant improvement in 
retinal sensitivity was observed only in eyes with no leakage 
from the CNV (P = 0.01 within central 2°, and P = 0.04 
within central 10°; Mann–Whitney U test).
Discussion
A significant improvement in the retinal sensitivities within the 
central 10° and a significant reduction in the FT were observed 
Table 1 Changes in visual acuity, foveal thickness, and mean retinal 
sensitivity
Baseline Month 3 Month 6
Visual acuity (logMAR) 0.61 ± 0.34 0.64 ± 0.47 
(P = 0.91)
0.65 ± 0.48 
(P = 0.80)
Foveal thickness (µm) 407 ± 144 253 ± 118 
(P = 0.0015*)
286 ± 153 
(P = 0.016*)
Mean retinal sensitivity, 
2 deg (dB)
1.7 ± 3.1 2.7 ± 4.3 
(P = 0.39)
3.3 ± 4.4 
(P = 0.11)
Mean retinal sensitivity, 
10 deg (dB)
2.8 ± 3.1 4.1 ± 3.7 
(P = 0.098)
5.1 ± 5.0 
(P = 0.02*)
Notes: statistical analyses were performed using Wilcoxon signed-rank test between 
baseline and month 3 and between baseline and month 6. *P  0.05, compared with 
the pre-treatment value.
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Figure 3 Relationship between changes in best-corrected visual acuity (BCVA) and changes in foveal thickness (FT).   There is a significant correlation between these two 
parameters at six months after photodynamic therapy (r = 0.51; P = 0.03).
Table 2 subjective improvement and changes in  VA, FT, and retinal 
sensitivity at six months after PDT
Improvement of symptomatic   
visual disturbance
P
Yes  
(n = 14, 74%)
Others  
(n = 5, 26%)
Changes in VA  
Changes in FT (µm)
-0.09 ± 0.12
-182.1 ± 172.9
0.35 ± 0.18
49.2 ± 103.5
0.001
0.012
Changes in retinal 
sensitivity (dB)
Within 2° 2.7 ± 5.0 -3.5 ± 4.2 0.016
Within 10° 2.3 ± 3.4 -1.3 ± 3.1 0.04
Notes: numerical data were analyzed using Mann–Whitney U test.
Abbreviations: CnV, choroidal neovascularization; FT, foveal thickness; PDT, 
photodynamic therapy;   VA, visual acuity.Clinical Ophthalmology 2009:3 487
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at six months after PDT for CNV due to AMD. However, 
the conventional BCVA, eg, Snellen visual acuity, in these 
eyes did not improve significantly, although 74% of these 
patients reported a subjective improvement of their central 
vision. These findings suggested that distance VA may not be 
a good way to assess the central visual function in eyes with a 
subfoveal CNV . This is because the CNV may affect the central 
vision and result in a scotoma which has only a slight influence 
on distant vision but has a strong effect on near vision.8,12
In agreement with this study, we have reported a signifi-
cant correlation between retinal sensitivity measured with the 
microperimeter and the VA and the FT in normal patients, 
and patients with diabetic macular edema.13
Eyes with AMD have different manifestations within the 
central 10°, eg, a CNV , subretinal hemorrhage, subretinal fluid, 
and a chorioretinal atrophy. The relationship between the retinal 
sensitivity and anatomic abnormalities based on funduscopic 
and angiographic findings showed that scotomas (not seen 
at 0 dB) were initially located in the areas corresponding to the 
classic and/or occult components of the CNV , PCV , chorioreti-
nal atrophy, and subretinal hemorrhages. The relative scotomas 
were located in the area of neurosensory retinal detachment, 
consistent with observations of Tezel and colleagues7 and 
Schmidt-Erfurth and colleagues.14 After PDT, there was a 
reduction of the subretinal fluid and subretinal hemorrhage, 
which led to the improvement of retinal sensitivity in the area 
surrounding the CNV . The size of the scotoma decreased 
with the regression of the CNV after PDT, however, the area 
of “not seen 0 dB” was still located in the area demonstrating 
subretinal fibrosis and chorioretinal atrophy.
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Figure 4 Relationship between changes in retinal sensitivity and the decrease in foveal thickness (FT).   The changes in retinal sensitivity were significantly correlated to the 
changes in foveal thickness. Data from within the central 2° (r = -0.49; P = 0.038) and within the central 10° (r = -0.59; P = 0.012).
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Figure 5 Relationship between changes in retinal sensitivity and changes in the best-corrected visual acuity (BCVA). Changes in retinal sensitivity was not significantly correlated 
to the BCVA within the central 2° (r = -0.39; P = 0.09 [Left]) and within the central 10° (r = -0.39; P = 0.09 [Right]).Clinical Ophthalmology 2009:3
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Histologically, CNVs consist mainly of  fibrous tissue which 
is not eliminated by PDT, and the increased subretinal fibrosis 
probably indicates that the photoreceptors have degenerated.15
In conclusion, significant improvements in retinal sensitivi-
ties within the central 10° and the decrease in FT were observed 
after PDT, although the VA was not significantly improved. 
A significant correlation was found between the improvement in 
retinal sensitivity and FT, and between the improvement in FT 
and BCVA after PDT. Improvements of the visual symptoms 
were most likely due to the improvements of retinal sensitivity 
and VA that was cause by the reduced FT after PDT. Retinal 
sensitivity measured by MP1 may be more sensitive to the 
changes in macular function because it assesses a larger retinal 
area than the conventional distant visual acuity. The ability to 
perform daily tasks is also strongly dependent on the preserva-
tion of the central visual field, therefore the retinal sensitivity 
within 10° could be a better indicator of practical visual capabili-
ties of patients. Thus, the retinal sensitivities measured by MP1 
may be a better way to assess the efficacy of PDT for AMD.
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